|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Cyfra ELISA Assay | Amyloid Beta (1-42) ELISA Assay | Anti-Tocilizumab (Actemra®) ELISA | BACE1 ELISA Assay | Deamidated Gliadin IgG ELISA Assay |
| Citations | | | | | |
| Catalog Number | 211-10 | 27711 | TM09021 | 27752 | KAPDTDGLG02 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase, non-competitive immunoassay (ELISA) for the determination of soluble cytokeratin 19 fragments in human serum. 510(k) cleared, can be used in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of BACE1 in human, mouse or rat brain extracts or cultured cell lysate. For research use only, not for use in diagnostic procedures. | Solid phase enzyme immunoassay (ELISA) for the detection of IgG antibodies to deamidated gliadin in human serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Adrenaline / Noradrenaline / Dopamine | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | S100B | CA 72-4 | Intact Proinsulin |
| Sample Type | Multiple | Serum and plasma. | Serum | Serum, Blood Plasma | Serum, EDTA-plasma, and cell culture supernatant. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1.4 to 47.6 ng/mL | 12.5 to 800 pg/mL | 0 / 6 to 200 ng/mL | 1.56 to 100 ng/mL | 25 to 400 U/mL |
| Sensitivity | Adrenaline: 0.25 ng/mL x C*; Noradrenaline: 0.1 ng/mL x C*; Dopamine 0.25 ng/mL x C*. Sensitivity based on calculated correction factor. | 1 ng/mL | Inquire | 0.79 U/mL | 6.83 pg/mL |
| Assay Time | 1 hr 45 mins (incubation) | Overnight + 1 hr 30 mins (incubation) | 2 hours, 10 min. total incubation time. | 2 hrs (incubation) | 1 hr 10 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |